It seems the real people who are working for the hbv cure are the HBF based in phili. imo
My suspicion is they are probably waiting for TDF to come off patent so they won't be held to random by Gilead to use it as a combo with NAPS.... Just my thoughts
Replicor announces publication of pre-clinical safety and pharmacokinetic data on NAPs
http://www.sciencedirect.com/science/article/pii/S2162253117301701
The same answer was given also in 2009 by replicor
hi, wrote to Replicor, see below what they answered me.
''We appreciate your interest in Replicor and our technology. Our drug is still in development and is expected to take a few years before it is approved for sale. As you may be aware, there are many clinical studies that need to be completed and reviewed by regulatory agencies before a drug can come on the market. We are of course doing everything we can to accelerate the approval process.''